AU2020200005B2 — Compliance-assisting module for an inhaler
Assigned to Norton Waterford Ltd · Expires 2022-02-24 · 4y expired
What this patent protects
COMPLIANCE-ASSISTING MODULE FOR AN INHALER ABSTRACT An inhaler (100) includes a mouthpiece cover (180), a pressure sensor, a first indicator and a second indicator. The first indicator may be configured to indicate based on a state of the cover (180), and the second indicator…
USPTO Abstract
COMPLIANCE-ASSISTING MODULE FOR AN INHALER ABSTRACT An inhaler (100) includes a mouthpiece cover (180), a pressure sensor, a first indicator and a second indicator. The first indicator may be configured to indicate based on a state of the cover (180), and the second indicator may be configured to indicate based on an output of the pressure sensor. For example, when the mouthpiece cover (180) opens, the first indicator may illuminate and a dose of medication may be transferred from a reservoir to a dosing cup. The second indicator may illuminate if an amount of inhaled medication reaches a predetermined threshold for successful inhalation. 24079701
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.